Home › Funds › Casdin Capital › DGX

Casdin Capital position in DGX

QUEST DIAGNOSTICS INC · Health Care

Casdin Capital reported holding 50,000 shares of DGX (QUEST DIAGNOSTICS INC) in its Q2 2026 13F filing — a position valued at US$10.6M, representing 0.53% of its reported portfolio and ranking #28 among its reported holdings. Casdin Capital has disclosed DGX holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)50.00K sh
Reported value held$10.60M
Portfolio Weight0.53%
First reportedQ4 2025
Last changeHold
Updated2026-10-05

Last updated: 2026-10-05 · Source: SEC EDGAR Form 13F-HR

How Casdin Capital's DGX position evolved

Casdin Capital first disclosed a stake in DGX in Q4 2025 at 50,000 shares (US$8.7M). The position peaked in Q2 2026 at 50,000 shares, worth US$10.6M. Across 3 filings, Casdin Capital held the position steady without any share-count change. The most recent filing (Q2 2026) shows 50,000 shares valued at US$10.6M.

Quarter by quarter

QuarterSharesValueChange
Q4 2025 50.00K $8.68M New
Q1 2026 50.00K $9.80M Hold
Q2 2026 50.00K $10.60M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About DGX and 13F data

DGX (QUEST DIAGNOSTICS INC) is a Health Care company. 31 other funds we track also report a position in DGX — the largest reported positions include Boston Partners (US$1.00B), EdgePoint Investment Group Inc. (US$476.4M), Grantham, Mayo, Van Otterloo & Co. LLC (US$400.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding DGX

All DGX fund holders →

FAQ

How long has Casdin Capital held DGX?

Casdin Capital has disclosed DGX holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

What is Casdin Capital's current position in DGX?

As of Q2 2026, Casdin Capital holds 50.00K shares of DGX (QUEST DIAGNOSTICS INC), valued at $10.60M, representing 0.53% of its reported portfolio and ranking #28.

Has Casdin Capital been buying or selling DGX?

In the latest 13F filing (Q2 2026), Casdin Capital held unchanged its position in DGX. The position peaked in Q2 2026 at 50.00K shares.

Which other funds hold DGX?

Other major institutional holders of DGX include Boston Partners, EdgePoint Investment Group Inc., Grantham, Mayo, Van Otterloo & Co. LLC, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.